GERN
NASDAQ · Biotechnology
Geron Corp
$1.30
-0.02 (-1.52%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,362.3% upside
Low Target
$12.94
Average Target
$19.01
High Target
$24.33
Current Price
$1.30
Current
$1.30
$1.30
Target
$19.01
$19.01
$12.94
$19.01 avg
$24.33
Scenario Analysis
Bear Case
$12.94
895.4%
Low target
Base Case
$19.01
+1,362.3%
Avg target
Bull Case
$24.33
+1,771.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.01
-35.3% from high
52-Week Low
$1.04
+25.0% from low
Target vs 52W High
$19.01
+845.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |